Sunbeam Products, Inc. – FDA Warning Letter, Aug 3, 2012

On December 4, 2012, the FDA issued a Warning Letter to Sunbeam Products, Inc. following an inspection from July 30 to August 3, 2012, which found their heating pads, classified as medical devices, to be adulterated. The inspection revealed non-conformity with the Quality System regulation (21 CFR Part 820) and Medical Device Reporting (21 CFR Part 803).

Key violations include: 1. **Design Control (21 CFR 820.30(a))**: Failure to establish and maintain adequate procedures for design control, with the Global Product Development Process lacking requirements for design input, output, review, validation, transfer, and history files. Sunbeam's proposed revisions were deemed inadequate due to a lack of technical detail and systemic corrective action. 2. **Design Change (21 CFR 820.30(i))**: Failure to establish and maintain procedures for the identification, documentation, validation, and approval of design changes. For example, a design change to correct heating pad controller overheating lacked documentation. The response was inadequate, lacking detailed information on systemic corrective actions for CAPA and design change control procedures. 3. **Corrective and Preventive Action (CAPA) (21 CFR 820.100(a))**: Failure to establish and maintain adequate CAPA procedures. A 20